Table of Contents

company-logo

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

Guardant Health Dividend Announcement

• Guardant Health does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Guardant Health dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Guardant Health Dividend History

Guardant Health Dividend Yield

Guardant Health current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Guardant Health stock? Use our calculator to estimate your expected dividend yield:

Guardant Health Financial Ratios

P/E ratio-8.85
PEG ratio-0.26
P/B ratio-75.49
ROE-1240.25%
Payout ratio-4.14%
Current ratio6.22
Quick ratio5.85
Cash Ratio3.49

Guardant Health Dividend FAQ

Does Guardant Health stock pay dividends?
Guardant Health does not currently pay dividends to its shareholders.
Has Guardant Health ever paid a dividend?
No, Guardant Health has no a history of paying dividends to its shareholders. Guardant Health is not known for its dividend payments.
Why doesn't Guardant Health pay dividends?
There are several potential reasons why Guardant Health would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Guardant Health ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Guardant Health has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Guardant Health a dividend aristocrat?
Guardant Health is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Guardant Health a dividend king?
Guardant Health is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Guardant Health a dividend stock?
No, Guardant Health is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Guardant Health stocks?
To buy Guardant Health you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Guardant Health stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.